Tag: FDA
Browse our exclusive articles!
FDA Approves Groundbreaking AI Device for Skin Cancer Detection, US
Discover the groundbreaking AI-powered medical device approved by the FDA for identifying skin cancer. Enhancing early detection and improving patient outcomes. Learn more now!
GSK Sells 300 Million Shares in Haleon, Cutting Stake in Consumer Healthcare Company
GSK reduces stake in Haleon, ECB probes Grifols, FDA rejects migraine treatment, Philippines bans Japan poultry imports, Netsmart explores sale, Pfizer employee convicted, US government speeds up insurance approvals, Spain breaks transplant record, DermaSensor's AI-powered device detects skin cancer. Explore healthcare industry developments.
FDA Approves AI-Powered Device for Real-Time Skin Cancer Detection
FDA Approves AI-Powered Device for Real-Time Skin Cancer Detection - A major milestone in dermatology, this AI-powered tool by DermaSensor Inc. uses spectroscopy and FDA-cleared algorithms to quickly and accurately detect basal cell carcinoma, squamous cell carcinoma, and melanoma. However, it should be used alongside clinical assessment. $199/month for five patients or $399/month for unlimited usage. References: [FDA Approves AI-Powered Device for Real-Time Skin Cancer Detection]
FDA’s AI Approval Clarity Urged by Medical Device Makers
Medical device makers urge FDA for clear guidelines on AI device approval. Radiology-related devices dominate recent approvals. Collaboration needed for innovation and safety.
MHRA, FDA, and Health Canada Publish Guiding Principles for MLMD Manufacturers
MHRA, FDA, and Health Canada collaborate on guiding principles to reduce regulatory burden for MLMD manufacturers. Enhancing patient safety and innovation.